ArticleJournal of clinical pharmacology2025

In Vitro and Clinical Evaluations of UGT1A1-, P-gp-, OATP1B1-, and BCRP-Mediated Drug-Drug Interactions of Belumosudil, a Potent ROCK2 Inhibitor.

Olivier Schueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.